Pulse Biosciences, Inc. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
Pulse Biosciences, Inc. (PLSE) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $4.97 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-06
- Pulse Biosciences, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $4.97M, a 4.16% decline year-over-year.
- Pulse Biosciences, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $1.91M, a 66.34% decline year-over-year.
- Pulse Biosciences, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-12-31 was $4.97M, a 26.84% decline year-over-year.
- Pulse Biosciences, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $5.62M, a 88.40% increase year-over-year.
- Pulse Biosciences, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $21.46M, a 57.93% increase from fiscal 2024.
- Pulse Biosciences, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $13.59M, a 89.19% increase from fiscal 2023.
- Pulse Biosciences, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $7.18M, a 38.34% increase from fiscal 2022.
- Pulse Biosciences, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $5.19M, a 64.45% decline from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-06-30 | $4.97M 10-Q · filed 2026-08-06 | $6.88M derived: sum of 2 quarters · filed 2026-08-06 | $11.86M derived: sum of 3 quarters · filed 2026-08-06 | $17.47M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $1.91M 10-Q · filed 2026-08-06 | $6.88M derived: sum of 2 quarters · filed 2026-08-06 | $12.50M derived: sum of 3 quarters · filed 2026-08-06 | $17.69M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $4.97M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $10.59M derived: sum of 2 quarters · filed 2026-02-19 | $15.78M derived: sum of 3 quarters · filed 2026-08-06 | $21.46M 10-K · filed 2026-02-19 |
| 2025-09-30 | $5.62M 10-Q · filed 2025-11-05 | $10.81M derived: sum of 2 quarters · filed 2026-08-06 | $16.49M 10-Q · filed 2025-11-05 | $23.28M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $5.19M 10-Q · filed 2026-08-06 | $10.87M 10-Q · filed 2025-08-12 | $17.66M derived: sum of 3 quarters · filed 2026-08-06 | $20.64M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $5.68M 10-Q · filed 2026-08-06 | $12.47M derived: sum of 2 quarters · filed 2026-08-06 | $15.46M derived: sum of 3 quarters · filed 2026-08-06 | $17.51M derived: sum of 4 quarters · filed 2026-08-06 |
| 2024-12-31 | $6.79M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $9.78M derived: sum of 2 quarters · filed 2026-02-19 | $11.83M derived: sum of 3 quarters · filed 2026-02-19 | $13.59M 10-K · filed 2026-02-19 |
| 2024-09-30 | $2.98M 10-Q · filed 2025-11-05 | $5.03M derived: sum of 2 quarters · filed 2025-11-05 | $6.79M 10-Q · filed 2025-11-05 | $10.14M derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | $2.05M 10-Q · filed 2025-08-12 | $3.81M 10-Q · filed 2025-08-12 | $7.16M derived: sum of 3 quarters · filed 2025-08-12 | $8.95M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $1.76M 10-Q · filed 2025-05-08 | $5.10M derived: sum of 2 quarters · filed 2025-05-08 | $6.90M derived: sum of 3 quarters · filed 2025-05-08 | $8.04M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $3.34M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $5.14M derived: sum of 2 quarters · filed 2025-03-31 | $6.29M derived: sum of 3 quarters · filed 2025-03-31 | $7.18M 10-K · filed 2025-03-31 |
| 2023-09-30 | $1.80M 10-Q · filed 2024-10-30 | $2.94M derived: sum of 2 quarters · filed 2024-10-30 | $3.84M 10-Q · filed 2024-10-30 | $4.58M derived: sum of 4 quarters · filed 2024-10-30 |
| 2023-06-30 | $1.14M 10-Q · filed 2024-08-19 | $2.04M 10-Q · filed 2024-08-19 | $2.79M derived: sum of 3 quarters · filed 2024-08-19 | $3.51M derived: sum of 4 quarters · filed 2024-08-19 |
| 2023-03-31 | $896.00K 10-Q · filed 2024-05-07 | $1.64M derived: sum of 2 quarters · filed 2024-05-07 | $2.37M derived: sum of 3 quarters · filed 2024-05-07 | $4.08M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $748.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $1.47M derived: sum of 2 quarters · filed 2024-03-28 | $3.18M derived: sum of 3 quarters · filed 2024-03-28 | $5.19M 10-K · filed 2024-03-28 |
| 2022-09-30 | $723.00K 10-Q · filed 2023-11-13 | $2.44M derived: sum of 2 quarters · filed 2023-11-13 | $4.44M 10-Q · filed 2023-11-13 | $8.05M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $1.71M 10-Q · filed 2023-08-10 | $3.72M 10-Q · filed 2023-08-10 | $7.33M derived: sum of 3 quarters · filed 2023-08-10 | $8.91M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $2.01M 10-Q · filed 2023-05-11 | $5.62M derived: sum of 2 quarters · filed 2023-05-11 | $7.20M derived: sum of 3 quarters · filed 2023-05-11 | $9.64M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $3.61M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $5.19M derived: sum of 2 quarters · filed 2023-03-31 | $7.64M derived: sum of 3 quarters · filed 2023-03-31 | $14.60M 10-K · filed 2023-03-31 |
| 2021-09-30 | $1.58M 10-Q · filed 2022-11-10 | $4.03M derived: sum of 2 quarters · filed 2022-11-10 | $10.99M 10-Q · filed 2022-11-10 | $13.38M derived: sum of 4 quarters · filed 2023-03-31 |
| 2021-06-30 | $2.45M 10-Q · filed 2022-08-10 | $9.41M 10-Q · filed 2022-08-10 | $11.80M derived: sum of 3 quarters · filed 2023-03-31 | $14.45M derived: sum of 4 quarters · filed 2023-03-31 |
| 2021-03-31 | $6.96M 10-Q · filed 2022-05-11 | $9.35M derived: sum of 2 quarters · filed 2023-03-31 | $12.00M derived: sum of 3 quarters · filed 2023-03-31 | $14.41M derived: sum of 4 quarters · filed 2023-03-31 |
| 2020-12-31 | $2.39M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $5.04M derived: sum of 2 quarters · filed 2023-03-31 | $7.45M derived: sum of 3 quarters · filed 2023-03-31 | $10.07M 10-K · filed 2023-03-31 |
| 2020-09-30 | $2.65M 10-Q · filed 2021-11-15 | $5.06M derived: sum of 2 quarters · filed 2021-11-15 | $7.69M 10-Q · filed 2021-11-15 | $11.23M derived: sum of 4 quarters · filed 2022-03-31 |
| 2020-06-30 | $2.41M 10-Q · filed 2021-08-09 | $5.04M 10-Q · filed 2021-08-09 | $8.59M derived: sum of 3 quarters · filed 2022-03-31 | $11.27M derived: sum of 4 quarters · filed 2022-03-31 |
| 2020-03-31 | $2.63M 10-Q · filed 2021-05-10 | $6.17M derived: sum of 2 quarters · filed 2022-03-31 | $8.85M derived: sum of 3 quarters · filed 2022-03-31 | $11.55M derived: sum of 4 quarters · filed 2022-03-31 |
| 2019-12-31 | $3.55M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $6.23M derived: sum of 2 quarters · filed 2022-03-31 | $8.93M derived: sum of 3 quarters · filed 2022-03-31 | $11.29M 10-K · filed 2022-03-31 |
| 2019-09-30 | $2.68M 10-Q · filed 2020-11-09 | $5.38M derived: sum of 2 quarters · filed 2020-11-09 | $7.74M 10-Q · filed 2020-11-09 | $10.09M derived: sum of 4 quarters · filed 2021-03-12 |
| 2019-06-30 | $2.70M 10-Q · filed 2020-08-10 | $5.06M 10-Q · filed 2020-08-10 | $7.41M derived: sum of 3 quarters · filed 2021-03-12 | $10.80M derived: sum of 4 quarters · filed 2021-03-12 |
| 2019-03-31 | $2.36M 10-Q · filed 2020-05-11 | $4.71M derived: sum of 2 quarters · filed 2021-03-12 | $8.11M derived: sum of 3 quarters · filed 2021-03-12 | $11.28M derived: sum of 4 quarters · filed 2021-03-12 |
| 2018-12-31 | $2.35M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $5.74M derived: sum of 2 quarters · filed 2021-03-12 | $8.92M derived: sum of 3 quarters · filed 2021-03-12 | $12.34M 10-K · filed 2021-03-12 |
| 2018-09-30 | $3.39M 10-Q · filed 2019-11-07 | $6.57M derived: sum of 2 quarters · filed 2019-11-07 | $9.99M 10-Q · filed 2019-11-07 | |
| 2018-06-30 | $3.17M 10-Q · filed 2019-08-08 | $6.59M 10-Q · filed 2019-08-08 | ||
| 2018-03-31 | $3.42M 10-Q · filed 2019-05-03 | |||
| 2017-12-31 | $10.93M 10-K · filed 2020-03-16 | |||
| 2016-12-31 | $870.00K 10-K · filed 2018-03-16 | |||
| 2015-12-31 | $402.00K 10-K · filed 2018-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |